Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Who We Fund
Since 1949, LLS has provided more than $1.6 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Sean Post
diffuse large B-cell lymphoma
Mark Hamilton
DLBCL and CAR-T
Wendy Stock
T-cell ALL
Anna Lee
AML
Enrico Tiacci
Hairy cell leukemia
Simona Colla
Myeloma biology
Roland Walter
Antibody-based AML therapies
ImCheck Therapeutics
immunotherapy, AML
Susan Schwab
cancer immunology
Suzanne Lentzsch
Myeloma
Robert Soiffer
transplantation
Christiane Querfeld
T-cell lymphoma
Timothy Graubert
AML and MDS biology
Kimberly Stegmaier
childhood blood cancers
Loren Walensky
pediatric leukemia
Peter Klein
MDS
Ann-Kathrin Eisfeld
Racial diversity in AML
Therese Vu
T-All and MLL
Martin Dreyling
Mantle Cell Lymphoma
Rgenta Therapeutics
RNA-targeting, AML
Eugenio Morelli
Myeloma
Roberta Zappasodi
lymphoma, immunotherapy
Jolanta Grembecka
leukemia therapeutics
Frederike Kramer
MPNs
Kasey Leger
pediatric blood cancers
Samuel Taylor
leukemia biology
Alieen Rowan
Adult T cell leukemia/lymphoma
Siddhartha Jaiswal
preleukemia
Kirsten Williams
leukemia, immunotherapy
Qing Yi
Novel CAR-T
Jianhua Yu
myeloma immunotherapy
Omar Abdel-Wahab
Hairy cell leukemia
Meng Li
Equity in Access
Sameer Parikh
COVID-19
Keisuke Ito
blood cancer stem cells
Mala Shanmugam
myeloma
Michael Rout
follicular lymphoma, CAR T
Arash Alizadeh
blood cancer biology and diagnosis
Jason Butler
aging and leukemia
Britta Will
Leukemia and pre-leukemia
Thomas Koehnke
leukemia
OncoPep
vaccine, smoldering myeloma
Christina Glytsou
leukemia therapeutics
Johann-Christoph Jann
AML/MDS
Suman Paul
T cell cancers and immunotherapy
Sergei Doulatov
Leukemias
Ricky Johnstone
lymphoma and myeloma
Yusuke Isshiki
DLBCL and GCB Lymphomas
Matthew Schwede
machine learning and AML
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Soheil Meshinchi
pediatric AML
Ryvu Therapeutics
AML, MDS
Liran Shlush
pre-leukemia
Andrew Lane
BPDCN
Christopher Flowers
clinical trial access
Daniel Herranz
T-ALL
Dren Bio
immunotherapy, LGLL
Marc Seifert
Hairy cell leukemia
Affimed
immunotherapy, PTCL
John Leonard
lymphoma research
Neha Mehta-Shah
T-cell lymphoma
David Ritchie
Hairy Cell Leukemia
Joachim Yahalom
Lymphoma
Alex Kentsis
pediatric leukemias
Koichi Takahashi
AML/MDS
Michael Keller
COVID-19, immunotherapy
Gongwei Wu
lymphoma biology
Justine Kahn
pediatric leukemia and lymphoma
Thomas LeBlanc
palliative care
Alexey Danilov
lymphoma
Jonas Jutzi
myeloproliferative neoplasms
Dan Landau
cancer evolution biology
Matteo Bellone
Smoldering multiple myeloma
Lori Muffly
Equity in Access
Daniel Pollyea
AML
Jennifer Woyach
CLL trials
Shannon McKinney-Freeman
transplant biology
Ravindra Majeti
preleukemia, AML
Piers Patten
COVID-19
Jonathan Licht
DNA biology, myeloma
Sisi Chen
leukemia
Jennifer Trowbridge
aging and leukemia
Yiman Liu
Epigenetics and leukemia
Amit Verma
AML/MDS
Philippe Armand
lymphoma and immunotherapy
Frederick Locke
lymphoma and immunotherapy
Margaret Shipp
lymphoma biology
Hao Jiang
leukemia biology
Kymera Therapeutics
protein degraders, DLBCL, TCL, LGLL
Jaroslaw Maciejewski
bone marrow failure
Lucy Godley
preleukemia
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Richard Lock
T-ALL
Craig Jordan
AML
Gianpietro Dotti
CAR T and AML
Constellation Pharmaceuticals
myeloproliferative neoplasms
Adi Nagler
Bronchiolitis obliterans after transplant
Juliette Bouyssou
leukemias and gender
Mitchell Geer
leukemia biology
Jian Xu
leukemia and MPN biology
Eirini Papapetrou
blood cancer stem cells
Yubin Zhou
peripheral T cell lymphoma
Catriona Jamieson
cancer stem cell biology
Lakshmi Nayak
brain tumors in lymphoma
Carl Allen
pediatric blood cancers
Alison Moskowitz
lymphoma therapeutics
Carl June
CAR T immunotherapy
Jun Qi
Myeloma
Jessica Stewart
Epstein-barr virus and lymphomas
Jianguo Tao
Mantle Cell Lymphoma
Mark Dawson
B-ALL and CAR-T resistance
Logan Spector
childhood leukemia epidimiology
Catherine Smith
leukemia
Clayton Smith
clinical trial access
Stephen Gottschalk
pediatric leukemia and CAR-T
Faron Pharmaceuticals
immunotherapy, AML, CMML
Shannon Maude
Immunotherapy for ALL
Caner Saygin
T-ALL
Dane Vassiliadis
blood cancer biology
Abintus Bio
immunotherapy, in vivo CAR
Michael Kharas
leukemia
Elvin Wagenblast
Down syndrome-associated leukemia
Carisma Therapeutics
immunotherapy, CAR-macrophage
Nitin Jain
CLL
Michael Savona
MDS and leukemia
Sami Malek
blood cancer biology
Noemí Puig Morón
Myeloma
John Crispino
MPNs, myelofibrosis
Hong Wen
AML
Steven Horwitz
T-cell lymphomas
Megan McNerney
AML/MDS
Katherine Borden
AML
Sarah Tasian
pediatric leukemias
Jenny Wang
AML
Qingyu Luo
BPDCN
Nirav Shah
CAR-T for lymphoma
Jayna Mistry
aging and leukemias
Todd Fehniger
NK cell immunotherapy and pediatric AML
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Matthew Frank
Lymphoma CART therapy
Xu Ji
Equity in Access
Daniel Thomas
Myelofibrosis
Christopher Porter
Leukemia, lymphoma
Caron Jacobson
lymphoma and immunotherapy
Helen Heslop
Immunotherapy
Areej El-Jawahri
transplant survivorship
Sigurður Kristinsson
Smoldering myeloma
William Matsui
Myeloma
Grant Challen
preleukemia, leukemia
George Vassiliou
pre-leukemia
Coleman Lindsley
AML/MDS
Amer Zeidan
MDS and AML
Jeremy Baeten
AML
Alex Herrera
lymphoma and immunotherapy
Thomas Kipps
Hairy Cell Leukemia
Cailin Collins
Leukemia and pre-leukemia
Takeshi Sugio
T-cell lymphoma
Inhye Ahn
CLL
Caroline Arber
myeloma CAR-T
Pietro Genovese
transplant and AML
Tomasz Skorski
myeloproliferative neoplasms, AML
Bruno Paiva
smoldering myeloma
Christian Steidl
B-cell lymphomas
Julia Maxson
AML
Stacie Dusetzina
Equity in Access
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Robert Kridel
follicular lymphoma
Steven Treon
Lymphomas and Waldenstrom's
Baochun Zhang
immunotherapy
Lev Kats
myeloma and epigenetics
Amin Sobh
Myeloma biology
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Thorsten Zenz
Hairy cell leukemia
Larry Kwak
Mantle cell lymphoma, immunotherapy
Sylvain Simon
Immunotherapy, CAR-T safety
Rizwan Romee
Immunotherapy
Robert Signer
cancer stem cell biology
Zhijian Qian
blood cancer stem cells
Yibin Yang
Lymphoma
Shirong Li
myeloma
Ravi Bhatia
transplantation
Saar Gill
AML immunotherapy
Maximilian Stahl
AML immunotherapy
Selina Chen-Kiang
Mantle cell lymphoma
Charles Mullighan
pediatric ALL
BioTheryX
protein degraders, AML
Daniel Lucas
bone marrow and leukemia biology
Alec Zhang
myeloma, immunotherapy
Grzegorz Nowakowski
Clinical trial access
Adam Olszewski
Follicular and marginal zone lymphoma
Johanna Melo-Cardenas
Primary Myelofibrosis
Kehan Ren
MDS
Timothy Ley
AML, precision medicine
Ruben Carrasco
Myeloma
Lindsey Montefiori
pediatric leukemia
Stephen Oh
myeloproliferative neoplasms
Srividya Swaminathan
pediatric, immunotherapy
Kirk Schultz
pediatric transplantation
Venkata Lokesh Battula
immunotherapy and AML
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Shan Lin
preleukemia, leukemia
Oreofe Odejide
Equity in Access
Ari Melnick
epigenetics and lymphoma
Jing Yang
Myeloma
Tanya Siddiqi
clinical trial access
Maria "Ken" Figueroa
aging and leukemia
Armin Rashidi
gut bacteria and transplant success
Robert Bradley
MDS
Sutro Biopharma
immunotherapy, NHL, myeloma
Jaehyuk Choi
T-cell lymphoma
Stephen Nimer
myeloid cancer biology
Matthew Davids
lymphoma therapeutics
Christopher Reilly
leukemia
Julia Paczkowska
immunobiology of Hodgkin's disease
Catherine Bollard
pediatric blood cancers and immunotherapy
Taishi Yonezawa
AML
Tycel Phillips
Mantle Cell Lymphoma
Paolo Strati
Non-Hodgkin Lymphoma
Luca Busino
DLBCL
Sattva Neelapu
DLBCL, CAR T
Ryan Wilcox
T-cell lymphoma
Kathleen Sakamoto
pediatric AML
Brian Walker
smoldering myeloma, MGUS
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Michael Wang
Mantle Cell Lymphoma
Jeffrey Magee
pediatric AML
Nicolas Nassar
pediatric leukemia
Christian Marinaccio
MLL leukemias
G. Greg Wang
DNA biology
Brian Dalton
DNA mutations and myeloid cancers
Randall Davis
CLL
Tyler Parsons
MPN and AML
John Pimanda
AML, MDS
Courtney Jones
AML metabolism
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
BioInvent International
immunotherapy, indolent NHL, CTCL
Jalpa Doshi
Equity in Access
Alexandra Stevens
childhood AML
Christopher Booth
BPDCN
Adam de Smith
pediatric ALL and Down Syndrome
Courtney DiNardo
clinical trials, AML
Marco Ruella
Immunotherapy for T-cell lymphoma
Dimericon
AML
Peng Ji
myeloproliferative neoplasms
Markus Muschen
leukemia and lymphoma biology
Nathan Ungerleider
lymphoma biology
Rong Lu
preleukemia, leukemia
Daniel Starczynowski
MDS and AML
Robert Orlowski
(Smoldering) Multiple Myeloma
Kevin Shannon
pediatric AML
Gareth Morgan
smoldering myeloma, MGUS
Daisuke Nakada
preleukemia, leukemia
Yan Liu
MDS
Aditi Shastri
AML, MDS
Alfred Garfall
myeloma immunotherapy
Forty Seven
immunotherapy, MDS, DLBCL
Liling Wan
AML
Kerry Rogers
CLL
Helen Parsons
Equity in Access
Tak Mak
Immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Christine Zhang
AML
David Fruman
novel combinations
Trent Hall
MDS
Dan Vogl
myeloma, microenvironment
Riccardo Dalla-Favera
diffuse large B-cell lymphoma
Eric Pietras
AML
Ronald Levy
immunotherapies, COVID-19
Michael Green
lymphoma biology
Nizar Bahlis
Myeloma immunotherapy
Gaurav Goyal
Erdheim-Chester Disease
Wendy Béguelin
follicular lymphoma
Rajni Kumari
AML
Kura Oncology
MLL leukemia, AML
F. Lennie Wong
Equity in Access
Ryotaro Nakamura
ALL, CAR T